Hepatic Lesion
Conditions
Keywords
Superb Micro-vascular Imaging, Hepatocellular Carcinoma
Brief summary
Superb Micro-vascular Imaging (SMI) based on the iBeam platform is used to evaluate the blood supply of solid tumors. Compared with color Doppler technology, the sensitivity, accuracy and consistency of the ability of SMI to display blood flow are evaluated. Thus, the investigators will use Superb-Microvascular imaging (SMI, Toshiba, Japan) for diagnosing hepatic lesions, which enable to detect slow micro vascular flow inside the tumor
Detailed description
To evaluate the diagnostic accuracy of SMI (primary outcome) when applying on the hepatic lesion. Each US findings during exam for patients with hepatic lesion were recorded by radiologist. Sample size calculation according to the primary outcome.
Interventions
Device: Superb-Microvascular imaging Superb-Microvascular imaging: new sonographic software technique on ultrasonography to detect low-vascular flow without use of contrast media for ultrasonography
Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. Visible hepatic lesion on US 2. Agree to participate in the study 3. Accessible follow-up imaging or pathological results
Exclusion criteria
1\. Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| diagnostic accuracy | 1 week preoperatively |
Countries
China
Contacts
Primary ContactPintong Huang, PhD
Outcome results
None listed